Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors

Abstract: The mitochondrial pyruvate carrier (MPC) exists in the mitochondria inner membrane which transports pyruvate to the mitochondrial matrix. Evidence shows that MPC is the breakthrough point to study the regulation of basic energy metabolism, the dysfunction of which may lead to metabolic disturbance. Due to its important metabolic function, MPC has been considered a potential therapeutic target for diabetes, alopecia, cancers, neurodegenerative diseases, and liver metabolic diseases. However, MPC' protein crystal structure is still not clear as the proteins involved were only identified 10 years ago, making it difficult to carry out rational drug design based on receptor structure. In this review, we summarize the latest applications of MPC in different diseases and discuss the recent advances in pharmacochemical strategies of small-molecule inhibitors of MPC, hoping to promote the development of specific MPC inhibitors.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors ; day:15 ; month:07 ; year:2024
Pharmaceutical fronts ; (15.07.2024)

Contributor
Huang, Yilei
Zhang, Han
Peng, Xinyan
Zhang, Qingwei

DOI
10.1055/s-0044-1788072
URN
urn:nbn:de:101:1-2408291028270.783194344745
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Huang, Yilei
  • Zhang, Han
  • Peng, Xinyan
  • Zhang, Qingwei

Other Objects (12)